Lactate dehydrogenase in dermatology practice
- PMID: 31755143
- DOI: 10.1111/ced.14134
Lactate dehydrogenase in dermatology practice
Abstract
Lactate dehydrogenase (LDH) is used in dermatology practice, particularly as a prognostic marker for cutaneous lymphoma. LDH is an intracellular enzyme involved in anaerobic glycolysis, and is found at low concentrations in the blood. LDH is produced in every tissue, thus cell damage releases LDH into the circulation, so the causes of elevated LDH levels are multiple. The utility of LDH in dermatology practice is reviewed, alongside current diagnostic and staging guidelines.
© 2019 British Association of Dermatologists.
References
-
- Lott JA, Wolf PL. Clinical Enzymology; A Case Orientated Approach. New York: Field, Rich and Associates, 1986.
-
- Jelinek D, Flores A, Uebelhoer M et al. Mapping metabolism: monitoring lactate dehydrogenase activity directly in tissue. J Vis Exp 2018; 136: e57760.
-
- Koseoglu M, Hur A, Atay A, Cuhadar S. Effects of hemolysis interference on routine biochemistry parameters. Biochem Med (Zagreb) 2011; 21: 79-85.
-
- Boyanton BL, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002; 48: 2242-7.
-
- Jacobs E, Hissen PJ, Propper W et al. Stability of lactate dehydrogenase at different storage temperatures. Clin Biochem 1986; 19: 183-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
